These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37026015)

  • 1. Active regression model for clinical grading of COVID-19.
    Sh Y; Dong J; Chen Z; Yuan M; Lyu L; Zhang X
    Front Immunol; 2023; 14():1141996. PubMed ID: 37026015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence in clinical care amidst COVID-19 pandemic: A systematic review.
    Adamidi ES; Mitsis K; Nikita KS
    Comput Struct Biotechnol J; 2021; 19():2833-2850. PubMed ID: 34025952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction and Feature Importance Analysis for Severity of COVID-19 in South Korea Using Artificial Intelligence: Model Development and Validation.
    Chung H; Ko H; Kang WS; Kim KW; Lee H; Park C; Song HO; Choi TY; Seo JH; Lee J
    J Med Internet Res; 2021 Apr; 23(4):e27060. PubMed ID: 33764883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expressions of MPV, P-LCR and NLR in patients with novel coronavirus disease 2019].
    Xu HM; Liu J; Gu CG; Zhang JD; Liu MR; Yuan FL; Liu SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Jul; 55(7):890-895. PubMed ID: 34304428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Machine Learning and Artificial Intelligence to predict SARS-CoV-2 infection from Full Blood Counts in a population.
    Banerjee A; Ray S; Vorselaars B; Kitson J; Mamalakis M; Weeks S; Baker M; Mackenzie LS
    Int Immunopharmacol; 2020 Sep; 86():106705. PubMed ID: 32652499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Could platelet indices have diagnostic properties in children with COVID-19?
    Dobrijević D; Antić J; Rakić G; Andrijević L; Katanić J; Pastor K
    J Clin Lab Anal; 2022 Dec; 36(12):e24749. PubMed ID: 36371787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease Severity in Moderate-to-Severe COVID-19 Is Associated With Platelet Hyperreactivity and Innate Immune Activation.
    Jakobs K; Reinshagen L; Puccini M; Friebel J; Wilde AB; Alsheik A; Rroku A; Landmesser U; Haghikia A; Kränkel N; Rauch-Kröhnert U
    Front Immunol; 2022; 13():844701. PubMed ID: 35359931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19.
    Zhang S; Liu Y; Wang X; Yang L; Li H; Wang Y; Liu M; Zhao X; Xie Y; Yang Y; Zhang S; Fan Z; Dong J; Yuan Z; Ding Z; Zhang Y; Hu L
    J Hematol Oncol; 2020 Sep; 13(1):120. PubMed ID: 32887634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.
    Zhou Y; Guo S; He Y; Zuo Q; Liu D; Xiao M; Fan J; Li X
    Front Cell Infect Microbiol; 2020; 10():322. PubMed ID: 32612961
    [No Abstract]   [Full Text] [Related]  

  • 13. Routine laboratory testing to determine if a patient has COVID-19.
    Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets and COVID-19.
    Rohlfing AK; Rath D; Geisler T; Gawaz M
    Hamostaseologie; 2021 Oct; 41(5):379-385. PubMed ID: 34695854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deep learning, 3D ultrastructural analysis reveals quantitative differences in platelet and organelle packing in COVID-19/SARSCoV2 patient-derived platelets.
    Matharu SS; Nordmann CS; Ottman KR; Akkem R; Palumbo D; Cruz DRD; Campbell K; Sievert G; Sturgill J; Porterfield JZ; Joshi S; Alfar HR; Peng C; Pokrovskaya ID; Kamykowski JA; Wood JP; Garvy B; Aronova MA; Whiteheart SW; Leapman RD; Storrie B
    Platelets; 2023 Dec; 34(1):2264978. PubMed ID: 37933490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.